Vasopressin for retained pregnancy tissue surgery

This study looks at whether managing a condition where pregnancy tissue remains in the womb (called retained products of conception) without immediate surgery is safe and effective. It might be an option for people who are stable and want to avoid more invasive procedures.

This study tests whether an injected gel helps prevent scar tissue from forming again after a procedure to remove leftover pregnancy tissue inside the uterus. If you qualify, you may receive the gel as part of a randomized trial to see if it lowers the chance of re-adhesions (re-forming tissue sticking).

This trial studies the best way to remove leftover pregnancy tissue after a first-trimester miscarriage. It compares approaches guided by a camera procedure in the uterus to see which helps most, especially for people who want to get pregnant again soon.

This study follows patients with retained products of conception (tissue left in the uterus after a pregnancy) to see how they are managed in real-world medical practice. You may join if an ultrasound shows a tissue area of at least half a centimeter.

This study compares two outpatient procedures—hysteroscopy and suction—to remove retained pregnancy tissue after a miscarriage in the first 3 months. The goal is to find which method works best and is safest for people who choose surgical treatment.

This trial tests if a simple gel injection works as well as gel plus a suction procedure for treating abnormal blood vessels in the uterus that cause bleeding after a miscarriage. If you had a miscarriage in the last 3 months and have ongoing bleeding, this study may offer a less invasive option.